Related Experiment Video
Updated: Jun 18, 2026
08:31
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
Detecting drug targets with minimum side effects in metabolic networks
1Beijing Wuzi University, School of Information, Beijing, People's Republic of China.
IET Systems Biology
|December 2, 2009
Summary
This study presents a novel integer linear programming model for identifying optimal drug targets in metabolic networks. The approach efficiently minimizes drug side effects, crucial for pharmaceutical research and therapeutics.
Area of Science:
- Systems Biology
- Computational Biology
- Metabolic Engineering
Background:
- High-throughput techniques generate vast genomic data, accelerating pharmaceutical research.
- Drug target discovery is essential for developing effective therapeutics and understanding disease mechanisms.
Purpose of the Study:
- To develop an efficient computational method for identifying optimal drug targets within metabolic networks.
- To minimize unintended side effects of potential drug compounds.
Main Methods:
- Formulated the drug target detection problem as an integer linear programming (ILP) model.
- Exploited unique characteristics of metabolic systems for precise problem formulation.
- Avoided heuristic manipulations to ensure optimal solution identification.
Main Results:
- The proposed ILP approach accurately and efficiently identifies optimal drug targets.
- Computational experiments on *Escherichia coli* and *Homo sapiens* metabolic pathways validated the method's effectiveness.
- The approach is scalable to large-scale metabolic networks.
Conclusions:
- The novel ILP model provides an exact and efficient solution for drug target identification.
- This method has significant potential for pharmaceutical applications by minimizing drug side effects.
- The approach is applicable to diverse organisms' metabolic networks.
Related Concept Videos
02:26Protein Networks
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
01:26Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...